ADC THERAPEUTICS
LIVE

Serial Number

99489063

Owner

ADC Therapeutics SA

Attorney

Tracy-Gene G. Durkin

Filing Date

Nov 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ADC THERAPEUTICS Trademark

Serial Number: 99489063

ADC THERAPEUTICS is a trademark filed by ADC Therapeutics SA on November 10, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ADC Therapeutics SA (35 trademarks)

Route de la Corniche 3B
Epalinges 1066 , CH

Entity Type: 99

Trademark Details

Filing Date

November 10, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2026 CNRT
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2026 CNEA
ASSIGNED TO EXAMINER
Mar 20, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2025 NWOS
NEW APPLICATION ENTERED
Nov 10, 2025 NWAP